These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34171548)

  • 1. A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.
    Bourassa L; Perchetti GA; Phung Q; Lin MJ; Mills MG; Roychoudhury P; Harmon KG; Reed JC; Greninger AL
    J Clin Virol; 2021 Aug; 141():104900. PubMed ID: 34171548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Quidel Sofia SARS FIA Test to the Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of COVID-19 in Symptomatic Outpatients.
    Beck ET; Paar W; Fojut L; Serwe J; Jahnke RR
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance.
    Jian MJ; Chung HY; Chang CK; Lin JC; Yeh KM; Chen CW; Lin DY; Chang FY; Hung KS; Perng CL; Shang HS
    Int J Infect Dis; 2022 Jan; 114():112-114. PubMed ID: 34758391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests.
    Tieman BC; Kovacs S; Rodgers MA; Mohaimani A; Gregory S; Christensen D; Moore JA; Schurig-Briccio L; Hartnett J; Kar A; Leeman A; Palmer A; Rogers L; Dragoo B; Muszynski S; Noblesmith D; Gardner S; Snipe-Bushey A; Kill A; Luo X; Cherukuri S; Rae T; Marohnic CC; Cloherty GA; Muerhoff AS; Hemken PM
    Biotechniques; 2022 Sep; 73(3):136-141. PubMed ID: 36004516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen-Based Diagnostic Tests for COVID-19.
    Golden A; Cantera JL; Lillis L; Phan TT; Slater H; Webb EJ; Peck RB; Boyle DS; Domingo GJ
    Microbiol Spectr; 2023 Jun; 11(3):e0373122. PubMed ID: 37166329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Four Point of Care (POC) Antigen Assays for the Detection of the SARS-CoV-2 Variant Omicron.
    Hardick J; Gallagher N; Sachithanandham J; Fall A; Siddiqui Z; Pekosz A; Manabe YC; Mostafa HH
    Microbiol Spectr; 2022 Jun; 10(3):e0102522. PubMed ID: 35616382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card.
    Perchetti GA; Huang ML; Mills MG; Jerome KR; Greninger AL
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33310764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pooled analysis of diagnostic performance of the instrument-read Quidel Sofia SARS antigen Fluorescent Immunoassay (FIA).
    Lippi G; Henry BM; Plebani M
    EJIFCC; 2023 Jul; 34(2):123-141. PubMed ID: 37455844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use, Safety Assessment, and Implementation of Two Point-of-Care Tests for COVID-19 Testing.
    Hahn M; Olsen A; Stokes K; Fowler RC; Gu R; Semple-Lytch S; DeVito A; Kurpiel P; Hughes S; Rakeman JL
    Am J Clin Pathol; 2021 Aug; 156(3):370-380. PubMed ID: 34302455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of SARS-CoV-2 antigen testing in symptomatic and asymptomatic adults: a single-center evaluation.
    Mitchell SL; Orris S; Freeman T; Freeman MC; Adam M; Axe M; Gribschaw J; Suyama J; Hoberman A; Wells A
    BMC Infect Dis; 2021 Oct; 21(1):1071. PubMed ID: 34663212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020.
    Almendares O; Prince-Guerra JL; Nolen LD; Gunn JKL; Dale AP; Buono SA; Deutsch-Feldman M; Suppiah S; Hao L; Zeng Y; Stevens VA; Knipe K; Pompey J; Atherstone C; Bui DP; Powell T; Tamin A; Harcourt JL; Petway M; Bohannon C; Folster JM; MacNeil A; Salerno R; Kuhnert-Tallman W; Tate JE; Thornburg N; Kirking HL; Sheiban K; Kudrna J; Cullen T; Komatsu KK; Villanueva JM; Rose DA; Neatherlin JC; Anderson M; Rota PA; Honein MA; Bower WA;
    J Clin Microbiol; 2022 Jan; 60(1):e0174221. PubMed ID: 34705535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Direct-Specimen SARS-CoV-2 Assay Performance Using Residual Patient Samples.
    Schroeder LF; Bachman MA; Idoni A; Gegenheimer-Holmes J; Kronick SL; Valdez R; Lephart PR
    J Appl Lab Med; 2022 May; 7(3):661-673. PubMed ID: 34755849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the Sofia SARS Antigen FIA Test and the PCR Test in Detection of SARS-CoV-2 Infection.
    Černila M; Logar M; Možina H; Osredkar J
    Lab Med; 2023 Mar; 54(2):e44-e48. PubMed ID: 35976956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France.
    Mboumba Bouassa RS; Veyer D; Péré H; Bélec L
    Int J Infect Dis; 2021 May; 106():8-12. PubMed ID: 33746093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the Sofia SARS-CoV-2 Rapid Antigen Test in Symptomatic and Asymptomatic Pediatric Patients.
    Freeman MC; Freeman TJ; Iagnemma J; Rasmussen J; Heidenreich K; Wells A; Hoberman A; Mitchell SL
    J Pediatric Infect Dis Soc; 2022 Sep; 11(9):417-421. PubMed ID: 35607860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel detection of SARS-CoV-2 RNA and nucleocapsid antigen in nasopharyngeal specimens from a COVID-19 patient screening cohort.
    Mayanskiy N; Brzhozovskaya E; Fedorova N; Lebedin Y
    Int J Infect Dis; 2021 Jul; 108():330-332. PubMed ID: 34091003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting.
    Okoye NC; Barker AP; Curtis K; Orlandi RR; Snavely EA; Wright C; Hanson KE; Pearson LN
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33509809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-market surveillance of six COVID-19 point-of-care tests using pre-Omicron and Omicron SARS-CoV-2 variants.
    Exner HM; Gregorchuk BSJ; Castor A-G; Crisostomo L; Kolsun K; Giesbrecht S; Dust K; Alexander DC; Bolaji A; Quill Z; Head BM; Meyers AFA; Sandstrom P; Becker MG
    Microbiol Spectr; 2024 Jul; 12(7):e0016324. PubMed ID: 38757955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Performance of an Antigen Test with RT-PCR for the Detection of SARS-CoV-2 in a Hospital Setting - Los Angeles County, California, June-August 2020.
    Brihn A; Chang J; OYong K; Balter S; Terashita D; Rubin Z; Yeganeh N
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):702-706. PubMed ID: 33983916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid SARS-CoV-2 antigenic test: definition, legislation of use, technological principles, analytical and clinical performance comparison].
    Lim I; Gautheret-Dejean A
    Ann Biol Clin (Paris); 2021 Apr; 79(2):123-142. PubMed ID: 33881398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.